245 related articles for article (PubMed ID: 9724025)
1. Effect of the high-affinity estrogen receptor ligand ICI 182,780 on the rat tibia.
Sibonga JD; Dobnig H; Harden RM; Turner RT
Endocrinology; 1998 Sep; 139(9):3736-42. PubMed ID: 9724025
[TBL] [Abstract][Full Text] [Related]
2. The estrogen antagonist ICI 182,780 reduces cancellous bone volume in female rats.
Gallagher A; Chambers TJ; Tobias JH
Endocrinology; 1993 Dec; 133(6):2787-91. PubMed ID: 8243306
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent effects of tamoxifen on long bones in growing rats: influence of ovarian status.
Moon LY; Wakley GK; Turner RT
Endocrinology; 1991 Sep; 129(3):1568-74. PubMed ID: 1874188
[TBL] [Abstract][Full Text] [Related]
4. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
[TBL] [Abstract][Full Text] [Related]
5. The effects of raloxifene on tibia histomorphometry in ovariectomized rats.
Evans G; Bryant HU; Magee D; Sato M; Turner RT
Endocrinology; 1994 May; 134(5):2283-8. PubMed ID: 8156931
[TBL] [Abstract][Full Text] [Related]
6. Effects of CP-336,156, a new, nonsteroidal estrogen agonist/antagonist, on bone, serum cholesterol, uterus and body composition in rat models.
Ke HZ; Paralkar VM; Grasser WA; Crawford DT; Qi H; Simmons HA; Pirie CM; Chidsey-Frink KL; Owen TA; Smock SL; Chen HK; Jee WS; Cameron KO; Rosati RL; Brown TA; Dasilva-Jardine P; Thompson DD
Endocrinology; 1998 Apr; 139(4):2068-76. PubMed ID: 9528995
[TBL] [Abstract][Full Text] [Related]
7. Lack of an effect of sodium zeolite A on rat tibia histomorphometry.
Firling CE; Evans GL; Wakley GK; Sibonga J; Turner RT
J Bone Miner Res; 1996 Feb; 11(2):254-63. PubMed ID: 8822350
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen and ICI 182,780 interactions with thyroid hormone in the ovariectomized-thyroidectomized rat.
Dipippo VA; Powers CA
J Pharmacol Exp Ther; 1997 Apr; 281(1):142-8. PubMed ID: 9103491
[TBL] [Abstract][Full Text] [Related]
9. Tissue-selective effects of continuous release of 2-hydroxyestrone and 16alpha-hydroxyestrone on bone, uterus and mammary gland in ovariectomized growing rats.
Lotinun S; Westerlind KC; Turner RT
J Endocrinol; 2001 Jul; 170(1):165-74. PubMed ID: 11431149
[TBL] [Abstract][Full Text] [Related]
10. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
[TBL] [Abstract][Full Text] [Related]
11. Idoxifene: a novel selective estrogen receptor modulator prevents bone loss and lowers cholesterol levels in ovariectomized rats and decreases uterine weight in intact rats.
Nuttall ME; Bradbeer JN; Stroup GB; Nadeau DP; Hoffman SJ; Zhao H; Rehm S; Gowen M
Endocrinology; 1998 Dec; 139(12):5224-34. PubMed ID: 9832463
[TBL] [Abstract][Full Text] [Related]
12. Effects of growth hormone and low dose estrogen on bone growth and turnover in long bones of hypophysectomized rats.
Kidder LS; Schmidt IU; Evans GL; Turner RT
Calcif Tissue Int; 1997 Oct; 61(4):327-35. PubMed ID: 9312204
[TBL] [Abstract][Full Text] [Related]
13. Relaxin stimulates uterine edema via activation of estrogen receptors: blockade of its effects using ICI 182,780, a specific estrogen receptor antagonist.
Pillai SB; Rockwell LC; Sherwood OD; Koos RD
Endocrinology; 1999 May; 140(5):2426-9. PubMed ID: 10218998
[TBL] [Abstract][Full Text] [Related]
14. Estrogen supplementation modulates effects of the endocrine disrupting pollutant PCB126 in rat bone and uterus: diverging effects in ovariectomized and intact animals.
Lind PM; Eriksen EF; Lind L; Orberg J; Sahlin L
Toxicology; 2004 Jul; 199(2-3):129-36. PubMed ID: 15147787
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of estrogen metabolites on bone and reproductive tissues of ovariectomized rats.
Westerlind KC; Gibson KJ; Malone P; Evans GL; Turner RT
J Bone Miner Res; 1998 Jun; 13(6):1023-31. PubMed ID: 9626634
[TBL] [Abstract][Full Text] [Related]
16. The high-affinity estrogen receptor antagonist ICI 182,780 has no effect on bone growth in young male rats.
Turner RT; Evans GL; Dobnig H
Calcif Tissue Int; 2000 Jun; 66(6):461-4. PubMed ID: 10821884
[TBL] [Abstract][Full Text] [Related]
17. Effects of the antiestrogenic environmental pollutant 3,3',4,4', 5-pentachlorobiphenyl (PCB #126) in rat bone and uterus: diverging effects in ovariectomized and intact animals.
Lind PM; Eriksen EF; Sahlin L; Edlund M; Orberg J
Toxicol Appl Pharmacol; 1999 Feb; 154(3):236-44. PubMed ID: 9931283
[TBL] [Abstract][Full Text] [Related]
18. Effects of estrogen receptor alpha- and beta-selective substances in the metaphysis of the tibia and on serum parameters of bone and fat tissue metabolism of ovariectomized rats.
Seidlová-Wuttke D; Prelle K; Fritzemeier KH; Wuttke W
Bone; 2008 Nov; 43(5):849-55. PubMed ID: 18708178
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of the antitumor efficacy of the antiprogestin, onapristone, by combination with the antiestrogen, ICI 164384.
Nishino Y; Schneider MR; Michna H
J Cancer Res Clin Oncol; 1994; 120(5):298-302. PubMed ID: 8126059
[TBL] [Abstract][Full Text] [Related]
20. The catechol estrogen, 4-hydroxyestrone, has tissue-specific estrogen actions.
Westerlind KC; Gibson KJ; Evans GL; Turner RT
J Endocrinol; 2000 Nov; 167(2):281-7. PubMed ID: 11054642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
